Publications by authors named "Lingli Sheng"

Claim this Profile
R
Research progress in the treatment of lipid metabolism disorder in patients with diabetic kidney disease by the integrated traditional Chinese and Western medicine.
Lingli Sheng, Ziyi Cao, Lin Wang, Youhua Xu, Dingkun Gui

Front Endocrinol (Lausanne)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LncRNA MEG3 promotes pyroptosis via miR-145-5p/TLR4/NLRP3 axis and aggravates cerebral ischemia-reperfusion injury.
Lei Li, Hao Zha, Wei Miao, Chunyan Li, Aimei Wang, Lingli Sheng

Metab Brain Dis· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Shenqi granule upregulates CD2AP and α-actinin4 and activates autophagy through regulation of mTOR/ULK1 pathway in MPC5 cells.
Lifeng Wei, Jun Yong, Xianwen Zhang, Chunyan Ling, Yansheng Wu, Lingli Sheng

J Ethnopharmacol· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alleviation of non-alcoholic fatty liver disease by Huazhi Fugan Granules is associated with suppression of TLR4/NF-κB signaling pathway.
Miaoqing Ye, Yinghui Tang, Jinyu He, Yueqing Yang, Xueyan Cao, Lingli Sheng

Clin Investig Arterioscler· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recent advances in chemistry and bioactivity of Sargentodoxa cuneata.
Wen Zhang, Chengpeng Sun, Shuang Zhou, Wenyu Zhao, Lin Wang, Lingli Sheng

J Ethnopharmacol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis